The present invention provides a fluorine-containing ether compound represented by the following formula:

R.sup.1—R.sup.2—CH.sub.2—R.sup.3—CH.sub.2—R.sup.4—R.sup.5

(in the formula, R.sup.3 represents a perfluoropolyether chain; R.sup.1 and R.sup.5 each independently represent any of an alkyl group which may have a substituent, an organic group having a double bond or a triple bond, and a hydrogen atom; —R.sup.2—CH.sub.2—R.sup.3 is represented by -[A]-[B]—O—CH.sub.2—R.sup.3; R.sup.3—CH.sub.2—R.sup.4— is represented by R.sup.3—CH.sub.2—O—[C]-[D]-; [A] is represented by Formula (4), [B] is represented by Formula (5), [C] is represented by Formula (6), and [D] is represented by Formula (7)):

##STR00001##

The present invention provides a fluorine-containing ether compound represented by the following formula:

R.sup.1—R.sup.2—CH.sub.2—R.sup.3—CH.sub.2—R.sup.4—R.sup.5

(in the formula, R.sup.3 represents a perfluoropolyether chain; R.sup.1 and R.sup.5 each independently represent any of an alkyl group which may have a substituent, an organic group having a double bond or a triple bond, and a hydrogen atom; —R.sup.2—CH.sub.2—R.sup.3 is represented by -[A]-[B]—O—CH.sub.2—R.sup.3; R.sup.3—CH.sub.2—R.sup.4— is represented by R.sup.3—CH.sub.2—O—[C]-[D]-; [A] is represented by Formula (4), [B] is represented by Formula (5), [C] is represented by Formula (6), and [D] is represented by Formula (7)):

##STR00001##

A branched degradable polyethylene glycol derivative with a high molecular weight that does not cause vacuolation of cells is provided. A branched degradable polyethylene glycol derivative represented by the following formula (1), containing, in a molecule, an oligopeptide that is degraded in the cells:

##STR00001##

wherein k.sub.1 and k.sub.2 are each independently 1-12, j.sub.1 and j.sub.2 are each independently 45-950, R is a hydrogen atom, a substituted or unsubstituted alkyl group having 1-12 carbon atoms, a substituted aryl group, an aralkyl group or a heteroalkyl group, Z is an oligopeptide that is degraded by enzyme in the cells, X is a functional group capable of reacting with a bio-related substance, and L.sub.1 and L.sub.2 are each independently a single bond or a divalent spacer.

A fluorine-containing ether compound characterized by being represented by the following formula (1):
R.sup.1—R.sup.2—CH.sub.2—R.sup.3—CH.sub.2—R.sup.4—R.sup.5  (1) In the formula (1), R.sup.3 is a perfluoropolyether chain. R.sup.2 and R.sup.4 are divalent linkage groups having a polar group and may be the same or different. R.sup.1 and R.sup.5 are bonded to an atom other than a carbon atom of R.sup.2 or R.sup.4. R.sup.1 and R.sup.5 are terminal groups composed of an organic group having 1 to 8 carbon atoms and may be the same or different. At least one of R.sup.1 and R.sup.5 is a chain organic group having 1 to 8 carbon atoms wherein one or more hydrogen atoms of the chain organic group is substituted with a group having an amide bond.

A fluorine-containing ether compound characterized by being represented by the following formula (1):
R.sup.1—R.sup.2—CH.sub.2—R.sup.3—CH.sub.2—R.sup.4—R.sup.5  (1) In the formula (1), R.sup.3 is a perfluoropolyether chain. R.sup.2 and R.sup.4 are divalent linkage groups having a polar group and may be the same or different. R.sup.1 and R.sup.5 are bonded to an atom other than a carbon atom of R.sup.2 or R.sup.4. R.sup.1 and R.sup.5 are terminal groups composed of an organic group having 1 to 8 carbon atoms and may be the same or different. At least one of R.sup.1 and R.sup.5 is a chain organic group having 1 to 8 carbon atoms wherein one or more hydrogen atoms of the chain organic group is substituted with a group having an amide bond.

The subject matter of this invention relates to hydrogel compositions and, more particularly, to hydrogel compositions comprising block copolymers (BCPs) capable of self-assembly into nanoparticles for the delivery and controlled release of therapeutic cargos.

The present disclosure provides a polyetheramine alkoxylate compound containing aromatic groups in the hydrophobe allowing the compound to exhibit unique functionality, high performance and low cost, but without the toxicity and/or skin and eye irritation problems associated with conventional polyetheramine compounds.

This invention provides preparations and applications of a highly strong and tough photo-crosslinked hydrogel material. The hydrogel materials are made from the o-nitrobenzyl phototriggers modified photosensitive polymer derivative, double bond groups modified polymer derivative, and photoinitiator. This invention significantly improved the properties of hydrogels by controlling the average molecular weight (arm length) of photosensitive poly (ethylene glycol) (with o-nitrobenzyl phototriggers modification) and its derivatives, and the molar ratio of o-nitrobenzyl phototriggers to poly (ethylene glycol) and its derivatives. Compared with prior technologies, the strength and/or toughness of the hydrogels in this invention are increased by one order of magnitude or even higher. These advances solve the problems of weak mechanical properties in current hydrogel materials and widen the applications of hydrogel materials.

A polyphenylene ether bismaleimide resin, a method for manufacturing the same, and a resin composition are provided. The polyphenylene ether bismaleimide (PPE-BMI) resin is obtained by a condensation reaction with a maleic anhydride and a primary amine compound as reactants. The primary amine compound is a polyphenylene ether diamine.

Bioactive coatings that are stabilized against inactivation by weathering are provided including a base associated with a chemically modified enzyme, and, optionally a first polyoxyethylene present in the base and independent of the enzyme. The coatings are optionally overlayered onto a substrate to form an active coating facilitating the removal of organic stains or organic material from food, insects, or the environment.